The Mississippi Supreme Court continues to smack down the will of the people on medical marijuana, a coerced drug treatment bill advances in California to the dismay of reformers, and more.

Medical Marijuana

Maine Legislature Approves Bill to Give Caregivers, Patients Input in Medical Marijuana Regulations. A bill that would require the state's Office of Marijuana Policy, which regulates both medical and recreational marijuana, to work with patients, caregivers, and medical marijuana enterprises in crafting regulations has passed both houses of the legislature. LD 1242 was passed as an emergency measure and has been enacted as law without the signature of Gov. Janet Mills (D), effective July 1. The bill was a response to proposed rules changes announced earlier this year by the Office of Marijuana Policy, which caregivers and the industry found onerous, including 24/7 surveillance and requiring growers to use the state's inventory tracking system, as is done with adult use marijuana. "This gives the people that are in the industry the real power in making and designing the laws and the rules that we will work around," said Susan Meehan, a medical marijuana caregiver, and chairperson of the Maine Cannabis Coalition.

Mississippi Supreme Court Refuses to Reconsider Ruling Throwing Out Medical Marijuana Initiative Victory. In a two-page decision released Thursday, the state Supreme Court has rejected a call for it to reconsider its May decision throwing out a voter-approved initiative to legalize medical marijuana in the state. In that decision, which essentially invalidated the state's initiative process, the court held that because the state constitution called for signatures to be gathered in all five of the state's congressional districts, the initiative was unconstitutional because the state has had only four congressional districts since redistricting in 2000. In its decision this week, the court said that the parties asking for a reconsideration should have done so last November and that "the present motion for leave to intervene is not well take and should be denied." There is pressure on Gov. Tate Reeves (R) to call a special session to enact the will of the voters, but he has yet to do so.

Drug Treatment

California Coerced Drug Treatment Bill Advances. A bill that would let Yolo County create a locked drug treatment facility for people convicted of "drug-motivated felonies" has already passed the Assembly and this week was approved nearly unanimously by the Senate Public Safety Committee. Assembly Bill 1542 would not be used for people simply convicted of drug possession or other misdemeanors, and those eligible would be "assessed by treatment providers who would decide the level and length of treatment." Those found suitable "would be given a choice of serving time in jail or prison or entering the soft secured facility where they would receive treatment to help them get well." While the bill has strong political support in Sacramento, there is strong opposition in the treatment and reform community. Even Human Rights Watch has weighed in, writing:"It [the bill] runs directly counter to the principle of free and informed consent to mental health treatment, which is a cornerstone of the right to health. Conflating health treatment and jailing, as envisioned by AB 1542, risks substantial human rights abuse, is ineffective as a treatment, and takes resources and policy focus away from initiatives that are much more likely to help people." The bill is now headed to the Senate Health Committee.

Harm Reduction

Rhode Island Legislature Approves Safe Injection Site Pilot Program. With a final vote Thursday, the state legislature has approved a bill, 2021-H 5245A/2021-S 0016B, to authorize a two-year pilot program to create "harm reduction centers" where people could "safely consume pre-obtained substances," otherwise known as a safe injection site. The bill would require local approval before such a site could open, but it could also face a federal challenge. An earlier effort to open a safe injection site in Philadelphia was blocked by the US 3rd Circuit Court of Appeals, which ruled it would violate the Controlled Substance Act. But that case was brought by a conservative US attorney during the Trump administration. To sue to block this bill -- if enacted into law -- would require a Biden administration US attorney to bring a case, and it's not clear that would happen. Also, Rhode Island sits in the 1st US Circuit Court district, not the 3rd, so that Philadelphia decision is not binding there.

House Democrats look to end the ban on legal marijuana sales in the nation's capital, the Rhode Island Senate approves a marijuana legalization bill, and more.

Marijuana Policy

House Democrats File Bill to End DC Marijuana Sales Ban. House Appropriations Financial Services and General Government (FSGG) Subcommittee Chairman Mike Quigley (D-IL) filed a wide-ranging bill Wednesday that would lift the ban on legal marijuana sales in the District of Columbia, as well as providing protection to financial institutions doing business with state-legal marijuana firms. The ban, in the form of a rider to the annual DC appropriations bill in Congress, was imposed in 2014, with the effort led by Rep. Andy Harris (R-MD), before city residents even voted for marijuana legalization later that year. It has remained in place ever since.The move comes even though President Biden specifically did not remove the congressional rider banning sales in his budget proposal last month. The bill is set to be voted on in the subcommittee Thursday, with the full Appropriations Committee taking it up next Tuesday, setting up a potential conflict with the Biden administration.

Connecticut Legalizes Marijuana. Gov. Ned Lamont (D) on Tuesday signed a marijuana legalization bill, Senate Bill 1201, making the state the 19th to end marijuana prohibition and the fourth to do this year, after New Mexico, New York, and Virginia. The bill legalizes the possession of up to one and a half ounces by people 21 and over, as well as setting up a system of taxed and regulated marijuana commerce with strong social equity provisions. The law takes effect on July 1, when using recreational marijuana becomes legal, but marijuana business licenses are not expected to be issued until the end of next year.

Rhode Island Senate Approves Marijuana Legalization Bill. The state Senate voted Tuesday night to approve an amended version of Senate Bill 568, which would legalize the possession, purchase, and cultivation of cannabis for personal use for adults 21 and older.The bill would also create a Cannabis Control Commission to regulate the legal marijuana market, tax marijuana sales at 20%, and create a social equity program to aid communities disproportionately harmed by marijuana prohibition. A House marijuana legalization bill filed at the end of May remains stuck in the House Judiciary Committee. The clock is ticking: The session ends in one week on June 30.

Ayahuasca

DEA Denies Religious Use Exemption to Florida Ayahuasca Church. The Drug Enforcement Administration (DEA) has officially denied the Soul Quest Church's request for a religious exemption allowing it to continue to legally provide ayahuasca, a substance containing the Schedule I drug DMT, for religious purposes. The church has been distributing ayahuasca and other substances to paying customers and gained unwanted scrutiny after a man died during an ayahuasca retreat in 2018. After that death, the DEA ordered the church to shut down its ayahuasca distribution, but the church has refused, instead fighting the order in the courts. Now, after the DEA decision, a federal judge is expected to rule soon on that decision, which could end the church's run. The church is relying on a generous interpretation of the 1993 Religious Freedom Restoration Act, under which both peyote use by the Native American Church and ayahuasca use by the Brazil-based church the Union of the Vegetable has been allowed. 

rfra

Harm Reduction

Los Angeles City Council Endorses Statewide Safe Injection Site Bill. The city council on Tuesday approved a resolution supporting a bill that would legalize pilot safe injection sites in a number of California cities, Senate Bill 57. The support comes as the city faces a drug overdose crisis, especially among the homeless, for whom the overdose rate jumped 33% in the first six months of last year. The bill has already passed the state Senate and is now before the Assembly Public Safety and Health committees. Even if the bill were to become law, it faces possible federal obstacles. When harm reductionists in Philadelphia sought to open a safe injection site, the Trump administration successfully blocked them in federal district court. The Biden administration has not made clear what its stance on the issue is.

On April 1, the Biden administration gave us the first big hint of what its drug policy will look like as it released the congressionally-mandated Statement of Drug Policy Priorities for Year One. The result is a definite mixed bag: a heavy dose of drug prevention, treatment, and recovery, along with an acknowledgement of harm reduction and a nod in the direction of racially-sensitive criminal justice reform, but also a reflexive reliance on prohibitionist drug war policies both at home and abroad.

And nothing about the most widely used illicit drug by far: marijuana. The word "marijuana" appears not once in the heavily annotated 11-page document, and the word "cannabis" only once, in the title of an academic research paper about the onset of teen drug use in the footnotes. That's perhaps not so surprising, given that, in response to a reporter's question, Vice President Harris said last week the administration was too busy dealing with other crises to worry about making good its campaign pledges about marijuana reform.

What is on the administration's mind is "the overdose and addiction crisis." Citing ever-increasing drug overdose deaths, the statement says "addressing the overdose and addiction epidemic is an urgent priority for [the] administration." But the solution is not to imprison drug users, with the statement noting that "President Biden has also said that people should not be incarcerated for drug use but should be offered treatment instead." (Underlying that seemingly humane approach is the errant presumption that all or most drug users are addicts in need of treatment when, depending on the drug, only between one in five and one in 10 drug users fit that dependent or problematic drug user description.)

Here are the Biden administration's drug policy priorities, all of which are gone into in detail in the statement:

• Expanding access to evidence-based treatment;
• Advancing racial equity issues in our approach to drug policy;
• Enhancing evidence-based harm reduction efforts;
• Supporting evidence-based prevention efforts to reduce youth substance use;
• Reducing the supply of illicit substances;
• Advancing recovery-ready workplaces and expanding the addiction workforce; and
• Expanding access to recovery support services.

Prioritizing treatment, prevention, and recovery is bound to be music to the ears of advocacy groups such as Faces and Voices in Recovery (FAVOR), whose own federal policy and advocacy priorities, while focusing on specific legislation, lean in the same direction. But the group also advocates for harm reduction practices the administration omits, particularly supervised consumption sites. FAVOR noted the administration's statement without comment.

As with the failure to even mention marijuana, the Biden administration's failure to include supervised consumption sites in its embrace of harm reduction -- it is wholeheartedly behind needle exchanges, for example -- is another indication that the administration is in no hurry no rush down a progressive drug reform path. And its prioritizing of supply reduction implies continued drug war in Latin America ("working with key partners like Mexico and Colombia") and at home, via support of High Intensity Drug Trafficking Areas (HIDTA) and "multi-jurisdictional task forces and other law enforcement efforts to disrupt and dismantle transnational drug trafficking and money laundering organizations." Prohibition is a hard drug to kick.

Still, naming advancing racial equity issues as a key priority is evidence that the Biden administration is serious about getting at some of the most perverse and corrosive outcomes of the war on drugs and is in line with its broader push for racial justice, as exemplified by Executive Order 13985, "Advancing Racial Equity and Support for Underserved Communities Through the Federal Government," issued on Biden's first day in office. And it is in this context that criminal justice system reform gets prioritized, although somewhat vaguely, with the promise of the creation of an "interagency working group to agree on specific policy priorities for criminal justice reform."

The Drug Policy Alliance (DPA) has some specific policy priorities for criminal justice reform, too, and they go far beyond where the administration is at. In its 2020 Roadmap for the incoming administration released in November, the group calls for federal marijuana legalization, drug decriminalization, and a slew of other criminal justice and policing reforms ranging from ending mandatory minimum sentencing and the deportation of non-citizens for drug possession to barring no-knock police raids, ending the transfer of military surplus equipment for counter-narcotics law enforcement, and dismantling the DEA. And the federal government should get out of the way of supervised consumption sites, or in DPA's politically attuned language "overdose prevention centers."

"We're glad the administration is taking important steps to address the overdose crisis -- by increasing access and funding to harm reduction services and reducing barriers to life-saving medications -- especially as people are dying at an alarming rate. We also appreciate their commitment to studying how to advance racial equity in our drug policies and best implement innovative practices on the ground. But it's clearly not enough. We need action," DPA Director of the Office of National Affairs Maritza Perez said in a statement responding to the administration's statement. "Black, Latinx and Indigenous people continue to lose their lives at the hands of law enforcement in the name of the drug war, and yet, the administration has chosen to prioritize increased funding for law enforcement. We need supervised consumption sites, not more money for police."

"And while we commend the Administration for taking steps to reduce employment discrimination, unless we address the biggest barrier for people trying to get a job -- past drug convictions and arrests -- we will still be left with significant inequities and racial disparities in the workplace," Perez continued. "It's time we get serious about saving lives and repairing the damage that has been caused by the drug war, particularly on Black, Latinx and Indigenous communities. We can start by passing federal marijuana reform and ending the criminalization of people for drugs in all forms."

Young drug reformers also had a few bones to pick with the administration's priorities. In their own statement in response to the administration, Students for Sensible Drug Policy applauded priorities such as more access to treatment and more research on racial equity, it complained that the administration priorities "fail to provide adequate support to Young People Who Use Drugs (YPWUD) in this country" -- especially those who use drugs non-problematically.

"There are no steps being taken to support YPWUD that do not want to and will not stop using drugs," SSDP said. "Young people have feared and faced the consequences of punitive drug policies and shouldered the burden of caring for their peers who use drugs for far too long. Young leaders calling for drug policy reform recognize that simply using drugs is not problematic and that we can support the safe and prosperous futures of People Who Use Drugs (PWUD) without forcing them to stop as a pre-condition for compassion, care, and opportunity."

Although only time will tell, for drug reformers, the Biden administration is looking like a step in the right direction, but only a step, and its policy prescriptions are limited by a vision of drug use rooted in the last century. Perhaps they can be pressured and prodded to plot a more progressive drug policy path.

The DEA points to Mexican drug cartels as the nation's greatest criminal drug threat, senators in Washington state move to reinstate the state's invalidated felony drug possession law, Dallas police are pushing to stop making small-time pot possession arrests, and more.

Marijuana Policy

California Bill Would End Most Workplace Marijuana Drug Tests. Assemblyman Bill Quirk (D-Hollywood) has introduced AB 1256, which would bar employers from using past evidence of marijuana use, such as hair or urine tests, to discriminate against employees. The bill is supported by CA NORML. "It is those tests that we want to ban, because they don't detect anything related to impairment," the group's longtime director Dale Gieringer said. The tests can show whether someone has used marijuana in the past, but not whether they are currently intoxicated.

Dallas Police Push No Arrests for Marijuana Possession Up to Two Ounces. Dallas Police are proposing to the city council Tuesday that it adopt a policy of no longer ticketing or arresting people caught with less than two ounces of marijuana. Pot busts accounted for 7% of all arrests in the city during the first three weeks of February, and 80% of those pot arrets were for fewer than two ounces. The proposal goes before the council's Public Safety Committee on Tuesday.

Harm Reduction

Rhode Island Senate Approves Bill Allowing Safe Consumption Sites for Illegal Drugs. The state Senate last week quietly approved SB 0016, which would authorize the creation of "Harm Reduction Centers" where drug users could inject drug under medical supervision. The bill would create an advisory committee to make recommendations to the state Health Department on regulating safe injection sites. A companion bill, HB 5245, though, is stuck in the House Committee on Health and Human Services, which has not set a date to vote on it.

Drug Policy

Washington State Senators Bill File to Bring Back Drug Possession Felony Crimes. Just days after the state Supreme Court threw out Washington's felony drug possession law, a pair of Democratic state senators, Mark Mullet and Steve Hobbs, have filed legislation to make possession of a controlled substance a felony again, SB 5468. The court threw out the law because it did not require prosecutors to prove that someone "knowingly" possessed drugs; this bill would merely add "knowingly" to the statute.

Law Enforcement

DEA Releases 2020 National Drug Threat Assessment. The DEA released its annual National Drug Threat Assessment Tuesday. The agency said that "the opioid threat remains at epidemic levels, affecting large portions of the country. Meanwhile, the stimulant threat, including methamphetamine and cocaine, is worsening both in volume and reach, with traffickers selling increasing amounts outside of traditional markets." DEA also pointed the finger at Mexican "transnational criminal organizations" as "the greatest criminal drug threat in the United States."

Washington House Approves Bill to Ban Chokeholds, No-Knock Warrants. The House on Saturday approved HB 1054, which would ban police from using chokeholds and using no-knock search warrants. The bill is now being considered by the Senate Law and Justice Committee.